Literature DB >> 21312192

CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.

Christian T Mayer1, Stefan Floess, Abdul Mannan Baru, Katharina Lahl, Jochen Huehn, Tim Sparwasser.   

Abstract

"Suppressor T cells" were historically defined within the CD8(+) T-cell compartment and recent studies have highlighted several naturally occurring CD8(+) Foxp3(-) Treg populations. However, the relevance of CD8(+) Foxp3(+) T cells, which represent a minor population in both thymi and secondary lymphoid organs of nonmanipulated mice, remains unclear. We here demonstrate that de novo Foxp3 induction in peripheral CD8(+) Foxp3(-) T cells is counter-regulated by DC-mediated co-stimulation via CD80/CD86. CD8(+) Foxp3(+) T cells fail to develop in TCR-transgenic mice with Rag1(-/-) background, similar to classical CD4(+) Foxp3(+) Tregs. Notably, both naturally occurring and induced CD8(+) Foxp3(+) T cells express bona fide Treg markers including CD25, GITR, CTLA4 and CD103, and show defective IFN-γ production upon restimulation when compared with their CD8(+) Foxp3(-) counterparts. However, utilizing DEREG transgenic mice for the isolation of Foxp3(+) cells by eGFP reporter expression, we demonstrate that induced CD8(+) Foxp3(+) T cells similar to activated CD8(+) Foxp3(-) T cells only mildly suppress T-cell proliferation and IFN-γ production. We therefore categorize CD8(+) Foxp3(+) T cells as a tightly controlled population sharing certain developmental and phenotypic properties with classical CD4(+) Foxp3(+) Tregs, but lacking potent suppressive activity.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312192     DOI: 10.1002/eji.201040913

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

1.  Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice.

Authors:  Susanna Choi; Hang-Rae Kim; Lin Leng; Insoo Kang; William L Jorgensen; Chul-Soo Cho; Richard Bucala; Wan-Uk Kim
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

Review 2.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

3.  Systemic immunogenicity of para-Phenylenediamine and Diphenylcyclopropenone: two potent contact allergy-inducing haptens.

Authors:  Jesper Dyrendom Svalgaard; Carina Særmark; Morten Dall; Karsten Buschard; Jeanne D Johansen; Kåre Engkilde
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

4.  A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells.

Authors:  Zachary S Buchwald; Chang Yang; Suman Nellore; Elena V Shashkova; Jennifer L Davis; Anna Cline; Je Ko; Deborah V Novack; Richard DiPaolo; Rajeev Aurora
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

5.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

6.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18

7.  Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation.

Authors:  Sun-Young Chang; Joo-Hye Song; Bayasi Guleng; Carmen Alonso Cotoner; Seiji Arihiro; Yun Zhao; Hao-Sen Chiang; Michael O'Keeffe; Gongxian Liao; Christopher L Karp; Mi-Na Kweon; Arlene H Sharpe; Atul Bhan; Cox Terhorst; Hans-Christian Reinecker
Journal:  Immunity       Date:  2012-12-13       Impact factor: 31.745

Review 8.  TGF-β activation and function in immunity.

Authors:  Mark A Travis; Dean Sheppard
Journal:  Annu Rev Immunol       Date:  2013-12-02       Impact factor: 28.527

9.  Optimal isolation of functional Foxp3+ induced regulatory T cells using DEREG mice.

Authors:  Abdul Mannan Baru; Christopher Untucht; Venkateswaran Ganesh; Christina Hesse; Christian T Mayer; Tim Sparwasser
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Foxp3+ regulatory T cells are required for recovery from severe sepsis.

Authors:  Franziska Kühlhorn; Matthias Rath; Katrin Schmoeckel; Katharina Cziupka; Huu Hung Nguyen; Petra Hildebrandt; Thomas Hünig; Tim Sparwasser; Jochen Huehn; Christian Pötschke; Barbara M Bröker
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.